Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc. (ASBP): 4 pipeline candidates · ~6 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
6.2 months
D/E 0.84 · 0% dilution
Lead: Approved
4 candidates
N/A
N/A
A transparent, data-derived signal for Aspire Biopharma Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$7.8M
Cash
$5.9M
Quarterly Burn
$3.0M
Runway
6.2 mo
Revenue
$28K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| aspireassist | Approved |
| buzz bomb | Approved |
| Instaprin | Preclinical |
| melatonin | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
10
Total value held
$150K
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 76,955 | $79K |
| geode capital management, llc | 43,384 | $45K |
| vanguard capital management llc | 15,718 | $16K |
| toronto dominion bank | 5,000 | $5K |
| vanguard fiduciary trust co | 2,856 | $3K |
| citigroup inc | 1,846 | $2K |
| osaic holdings, inc. | 2 | $2 |
| avion wealth | 1,352 | $1 |
| caitong international asset management co., ltd | 1 | $1 |
| sbi securities co., ltd. | 1 | $1 |
Frequently asked questions
How many drug candidates are in Aspire Biopharma Holdings Inc.'s pipeline?
Aspire Biopharma Holdings Inc. (ASBP) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Aspire Biopharma Holdings Inc.'s lead drug candidate?
Aspire Biopharma Holdings Inc.'s most advanced tracked candidate is aspireassist (Approved) for Gastroenterology, Urology.
What is Aspire Biopharma Holdings Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Aspire Biopharma Holdings Inc. has approximately 6.2 months of cash runway.
What is Aspire Biopharma Holdings Inc.'s market capitalization?
Aspire Biopharma Holdings Inc.'s market capitalization is approximately $7.8M.
Who is the CEO of Aspire Biopharma Holdings Inc.?
Mr. Kraig T. Higginson is the chief executive officer of Aspire Biopharma Holdings Inc. (ASBP).
Get the full picture on Aspire Biopharma Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.